Next GenerationLongevity 2026

Eric Verdin, MD

Showed that the ketone body β-hydroxybutyrate blocks HDACs, a molecular link between fasting, metabolism, and aging.

President and CEO of the Buck Institute for Research on Aging, the first independent institute devoted solely to aging. Author of more than 270 papers on how metabolism and diet regulate sirtuins, HDACs, and the aging process.

Pat Carroll, MD

Leads clinical care at Hims & Hers, setting standards for outcomes and patient safety across one of the world’s largest direct-to-consumer health platforms.

Global Chief Medical Officer at Hims & Hers (NYSE: HIMS), where he oversees the platform’s clinical model, including care quality, treatment outcomes, and patient safety.

Makoto Kuro-o, MD, PhD

Discovered klotho, the aging-suppressor gene, and went on to show that raising it extends lifespan in mice.

Professor in the Division of Anti-Aging Medicine at Jichi Medical University’s Center for Molecular Medicine, where his lab studies the FGF23–klotho system linking phosphate metabolism, kidney disease, and accelerated aging.

Florence Comite, MD

Founded Yale’s first center for women’s health, then built one of America’s earliest precision-medicine longevity practices.

Endocrinologist and founder of the Comite Center for Precision Medicine & Healthy Longevity in New York. Trained at the NIH, with 25 years on the Yale School of Medicine faculty.

Photo: Nick Coleman, Coleman Photo/Graphix · CC BY 4.0 · cropped and optimized

Yoshiki Sawa, MD, PhD

Cardiac surgeon and Japanese leader in regenerative medicine and longevity medicine.

Chairman of the Organization for Future Medicine and Professor Emeritus at Osaka University Graduate School of Medicine.

Kenji Shibuya, MD, DrPH

Renowned expert in global and population health, and former Chief of Health Policy at the WHO.

Chief Executive Officer of Medical Excellence JAPAN.

Atsushi Sorita, MD, MPH

Bridges frontline clinical care in Japan and the U.S. with McKinsey’s global health practice, and now leads Japan-based efforts to turn healthcare data and AI into sustainable systems of care.

Partner at McKinsey & Company in Tokyo and Japan lead for the McKinsey Health Institute (MHI). Trained at the University of Tokyo, Mount Sinai Beth Israel, and Mayo Clinic, he practiced medicine for eight years in Japan and the United States before joining McKinsey in 2015.

Keizo Takemi

Japan’s 27th Minister of Health, Labour and Welfare (2023–2024) and the country’s leading political figure in global health.

Former Minister of Health, Labour and Welfare of Japan and Chair of the Asian Population and Development Association (APDA). Over five terms in the House of Councillors between 1995 and 2025 he served as State Minister of Health, Labour and Welfare and as Chairman of the Liberal Democratic Party caucus in the upper house, and was WHO Goodwill Ambassador for Universal Health Coverage from 2019 to 2022.

Kiran Krishnan

Helped develop the first all-spore-based probiotic and ran the human trials that established the category.

Research microbiologist and co-founder of Microbiome Labs, focused on probiotics, intestinal permeability, and the human microbiome.

Anthony Gabriel, MD

Co-founded Radiology Partners and built it into the largest physician-led radiology practice in the United States.

Co-founder and President of Radiology Partners, and co-founder of ElaraMD. Previously Chief Information Officer at DaVita.

Elizabeth Yurth, MD

Founded Boulder Longevity Institute in 2006 and now trains clinicians in cellular medicine through its Human Optimization Academy.

Co-founder and Chief Medical Officer of Boulder Longevity Institute; double board-certified in physical medicine and rehabilitation and in anti-aging and regenerative medicine.

Tom Nodine

Pioneered the use of epigenetic age testing in life insurance underwriting; previously led global insurance strategy at KPMG.

Founder and CEO of Human Life Expectancy Inc., working at the intersection of epigenetics, insurance, and longevity.

Tim Doyle

Built Eucalyptus, the group behind Juniper and Pilot, into the telehealth company Hims & Hers acquired for US$1.15 billion.

SVP of International at Hims & Hers; co-founder and former CEO of Eucalyptus, the Australian digital health group.

Olivia Ly Lesslar, MBBS

A leading clinical voice in psychoneuroimmunology: how mind, nervous system, and immunity together shape chronic disease.

Australian-educated physician working across preventive medicine, longevity medicine, and complex multisystem conditions including neurodegeneration.

Alexander Grinberg, MD

Translates epigenomic and multi-omic data into individual clinical plans through Infinity Epigenetics, the practice he founded in 2023.

Integrative medicine physician in San Francisco, focused on epigenetic health and longevity medicine, and a clinical advisor to biotech teams building longevity assays.

Abid Husain, MD

Triple board-certified in cardiology, internal medicine, and functional medicine, with more than 20 years in clinical practice.

Cardiologist and integrative medicine physician in Colorado; Consulting Physician and Scientific Advisor for Hone Health.

Emilian Popa

Founded Ilara Health to bring diagnostics to Sub-Saharan Africa, and now builds AI-driven longevity clinics across three continents.

Founder and CEO of Expand Health, a global AI-powered longevity clinic network, and co-founder and CEO of Expand Home.

Shalin Y. Shah

Was instrumental in the development and FDA approval of KYZATREX, an oral testosterone undecanoate therapy, and in launching it through US telemedicine platforms and clinical channels.

Chief Executive Officer of Marius Pharmaceuticals, the company behind KYZATREX (testosterone undecanoate) CIII capsules. He moved into healthcare from a global investment background and speaks widely on metabolic health and testosterone policy.

Martin O’Dea

Founded Longevity Summit Dublin and co-conceived the Dublin Longevity Declaration, the consensus call to expand healthy-lifespan research.

CEO of Longevity Events Limited, which runs the annual Longevity Summit Dublin at Trinity College Dublin, and of Applied Longevity Intelligence Services. He holds an MBA, has lectured in business strategy at Dublin Business School, and advised the International Longevity Alliance on organisational structure and growth.

Andrea Maier, MD, PhD

Director and Co-founder of the NUS Academy for Healthy Longevity.

Director and Co-founder of the NUS Academy for Healthy Longevity. She is the Oon Chiew Seng Professor in Medicine, Healthy Ageing and Dementia Research at the NUS Yong Loo Lin School of Medicine, and Professor of Gerontology at Vrije Universiteit Amsterdam. She co-founded the Singapore longevity clinic Chi Longevity.

Brian Kennedy, PhD

Published the first paper linking sirtuins to aging, a 1995 Cell study showing a SIR4 mutation extends yeast lifespan, and later led the Buck Institute as president and CEO.

Distinguished Professor in the Departments of Biochemistry and Physiology at the Yong Loo Lin School of Medicine, National University of Singapore, where he directs the Healthy Longevity Translational Research Programme. He was president and CEO of the Buck Institute for Research on Aging from 2010 to 2016.

Leo Grady, PhD

Was CEO of Paige when Paige Prostate became the first AI product FDA-authorized in pathology, and now reads the gut microbiome with a proprietary language model at Jona.

Founder and CEO of Jona, which sequences at-home gut microbiome samples and applies a proprietary large language model to generate personalized reports. Previously CEO of Paige, senior vice president of engineering at HeartFlow, and a principal research scientist at Siemens Corporate Research.

Erin Pagel, M.S., M.H.I.

Works on the operational side of care delivery at Mayo Clinic in Rochester, and co-authored an MGMA Connection article on engaging staff and fostering joy at work.

Operations administrator at Mayo Clinic in Rochester, Minnesota, who began her Mayo career as a clinical laboratory technologist. She is a co-author of the MGMA Connection article “Engaging staff and fostering joy at work.”

Ryan T. Hurt, MD, PhD

Directs Mayo Clinic’s home parenteral and enteral nutrition program, and its Rochester post-COVID care and research programs.

Chair of the Division of General Internal Medicine at Mayo Clinic in Rochester, Minnesota, and Professor of Medicine at Mayo Clinic College of Medicine. He earned his PhD in physiology and biophysics at the University of Louisville, served as president of the American Society for Parenteral and Enteral Nutrition, and has published more than 200 peer-reviewed papers.

Noah Waxman

Co-founded Cactus and worked with Mount Sinai to design Lab100, a hybrid clinic and research center built so that a digitally enabled room automates health data collection and the physician, unburdened by paperwork and data entry, can fully engage with the patient.

CEO and co-founder of Cactus, a New York strategy and design firm that plans, designs and builds products, spaces and experiences for health systems including Mount Sinai, Mayo Clinic, AdventHealth and Wellstar Health System. An alumnus of NYU’s Interactive Telecommunications Program (ITP), he was a strategy director at Redscout before co-founding Cactus.

Michael Offerman

Has spent his career helping consumer brands design their physical and digital experiences, with a focus on healthcare; he has worked with Hilton, Uber, Walgreens Health, Oscar Health, Mayo Clinic, AARP and AdventHealth.

Director of Strategy at Cactus, a New York strategy and design firm working with healthcare organizations, startups and wellness brands, where he focuses on user experience at the intersection of business strategy, brand positioning and experiential design. He holds a bachelor’s degree in architecture and an MBA from Washington University in St. Louis.

Robert Bosnak, NCPsyA

Created Embodied Imagination, a Jungian dreamwork method, and adapted it with oncologist Anthony Back into the DREAM Protocol for psilocybin integration.

Jungian psychoanalyst who trained at the C.G. Jung Institute in Zurich and developed Embodied Imagination, a method for working with dreams and memories. Past president of the International Association for the Study of Dreams, author of A Little Course in Dreams, and faculty in the Department of Psychiatry at SUNY Upstate Medical University.

Elise Lilliehöök

Co-founded Mingla, an engagement platform that gamifies networking at live events, after serving as COO of 29k.

CEO and co-founder of Mingla, a behavioural engagement platform that event organisers use to activate audiences during live experiences, founded with Ash Pournouri and Andreas Grape. She was previously COO of 29k, co-owned by the Norrsken Foundation and the Ekskäret Foundation, and works as a board professional and angel investor.

Shoma Chaudhury, MA

Co-founded the investigative magazine Tehelka, and now convenes SYNAPSE, an Indian conclave on science, technology and society.

Indian journalist and editor, founder of Lucid Lines and founder-director and curator of SYNAPSE, an annual science, technology and society conclave. She was co-founder and managing editor of Tehelka, founding editor-in-chief of CatchNews, and co-founder of the THiNK conference.

Anthony Molina, PhD

Develops blood-based mitochondrial bioenergetic profiling as a minimally invasive measure of aging, and co-leads UC San Diego’s central lab for the XPRIZE Healthspan competition.

Professor of medicine at UC San Diego School of Medicine, holder of the Ben and Wanda Hildyard Endowed Chair for Mitochondrial and Metabolic Diseases, and research chief of the Division of Geriatrics, Gerontology and Palliative Care. Scientific director of the Stein Institute for Research on Aging since 2022.

Julie Ying Baron

Co-founded LiveBeyond and its BeyondClock platform, which estimates biological age and mortality risk from routine clinical blood data.

Co-founder and board member of LiveBeyond, a longevity company whose BeyondClock platform reads biological age from clinical blood biomarkers alongside NUS aging biologist Brian Kennedy. She came to longevity from commodities trading and space resources.

Yani Langenberg, MD

Spent over a decade bridging scientific founders and the investors and clinicians who decide whether a technology actually reaches practice, at Amgen and Novartis, and now as a three-time founder.

Chief Business Officer at ALIS, whose platform pairs peer-reviewed aging science with a reasoning engine that maps a patient’s biological profile to intervention information ranked by evidence strength, with every conclusion traceable rather than a black box. A physician by training who has since founded three companies and held roles at Amgen and Novartis.

Miwako Ishido, PhD

Turned Tamotsu Yoshimori’s Osaka University autophagy research into AutoPhagyGO, which measures autophagy activity for industry partners and has carried it into human trials; it is now an XPRIZE Healthspan semifinalist.

President and CEO of AutoPhagyGO since June 2020, having joined as COO when the Osaka University spin-out was founded in 2019. A scientist by training (University of Tokyo Faculty of Science, Kyoto University graduate school and a postdoctoral fellowship at the Scripps Research Institute), she went on to work in marketing and medical affairs at Janssen and AbbVie. EY Winning Women 2021 finalist and a member of the EY Entrepreneurial Winning Women Asia-Pacific Class of 2023.

Yuta Lee, MBA

Founded Accelerated Biosciences to commercialize the human trophoblast stem cell platform his father, Professor Jau-Nan Lee, isolated and characterized in 2003, and was instrumental in securing the patents that protect it.

Founder and CEO of Accelerated Biosciences, which he started in 2013 to commercialize the pluripotent human trophoblast stem cell (hTSC) platform; the company has since been awarded dozens of patents worldwide. Before that he spent eight years in property and casualty insurance, at ULLICO, at AIG in Taipei and at Chubb. He holds a dual B.A. in economics and legal studies from UC Berkeley and an MBA from CEIBS in Shanghai.

Jian Fransén, MD, PhD

Researches clinical biomarkers of aging that sharpen cancer-risk prediction, and precision medicine in aging and oncology. Clinical trial investigator that has served as Investigator in 40+ clinical trials. Longevity biotech advisor.

Physician-scientist at Karolinska Institutet, affiliated with Sara Hägg’s molecular epidemiology of aging group and with reconstructive plastic surgery and global surgery. His work spans clinical biomarkers of aging, innovative clinical trial design, and precision medicine. He has served as investigator in 40+ clinical trials including age-related disease, oncology, and medical devices. He currently advises multiple clinics and biotech companies in the longevity industry.

Tsin Uin Foong, MBBS, MRCGP

Architect of Osler Health’s approach to care: personalized, precision-driven family medicine that looks beyond symptoms to uncover their root cause.

Co-founder and Chief Medical Officer of Osler Health International in Singapore, with more than 25 years of clinical experience across the UK and Singapore. A family physician who trained at the Royal Free and University College London Medical School and is a Member of the Royal College of General Practitioners (UK), she focuses on preventive health and healthy longevity built on strong primary care, with particular interests in menopause and women’s health, child health and mental health. She is a founding member of the Singaporean Society of Lifestyle Medicine.

Chongyang Wang

Contributed to TimePie’s White Paper on China’s Longevity Medicine and Anti-Aging Industry, drawing on years of field research with leading clinics across China, East Asia, Europe and North America.

Head of Insights & International Programs at TimePie, one of the leading longevity technology platforms in China. She has contributed to TimePie’s longevity industry research, including the White Paper on China’s Longevity Medicine and Anti-Aging Industry. Years of field research and exchanges with leading clinics and institutions across China, East Asia, Europe and North America have given her a strong international network and a deep understanding of clinic models, diagnostics, intervention approaches and market development.